Related Experiment Videos
Functional electrical stimulation on chronic and acute hemiplegic shoulder subluxation
1Faculty of Physical Therapy, National Yang-Ming University, Shih-Pai, Taiwan.
American Journal of Physical Medicine & Rehabilitation
|July 13, 2000
Summary
Functional electrical stimulation (FES) effectively reduced shoulder subluxation in hemiplegic patients with short postonset duration. However, FES was not effective for chronic shoulder subluxation lasting over one year.
Area of Science:
- Rehabilitation Medicine
- Neuroscience
- Biomechanics
Background:
- Shoulder subluxation is a common complication in hemiplegic patients.
- Effective management strategies are crucial for improving patient outcomes and function.
Purpose of the Study:
- To evaluate the efficacy of functional electrical stimulation (FES) for managing acute and chronic shoulder subluxation in hemiplegic individuals.
- To compare the effectiveness of FES based on the duration of postonset symptoms.
Main Methods:
- A randomized controlled trial design was employed, categorizing participants into short-duration (acute) and long-duration (chronic) groups.
- Participants were further assigned to experimental (FES) or control subgroups.
- The experimental groups received FES targeting the supraspinatus and posterior deltoid muscles for up to 6 hours daily over 6 weeks, with progressive increases in duration and intensity.
Main Results:
- The short-duration experimental group demonstrated significant reduction in shoulder subluxation, confirmed by X-ray, after the initial FES treatment compared to controls.
- No significant improvement in subluxation was observed in the long-duration experimental group after the first FES treatment.
- A second FES treatment program yielded insignificant changes in shoulder subluxation for both short- and long-duration groups.
Conclusions:
- Functional electrical stimulation (FES) is an effective intervention for reducing shoulder subluxation in hemiplegic patients with recent onset (<1 year).
- FES demonstrated limited efficacy for managing chronic shoulder subluxation in patients with symptoms exceeding one year postonset.